caprolactone has been researched along with Graft Occlusion, Vascular in 3 studies
*Graft Occlusion, Vascular: Obstruction of flow in biological or prosthetic vascular grafts. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ao, Q; Arslan Ahmad, M; Hao, L; Ma, Y; Mao, X; Tao, M; Wang, Y; Wei, H | 1 |
De Valence, S; Dillon, J; Dimon, Z; Giliberto, JP; Gurny, R; Moeller, M; Mugnai, D; Saat, SA; Sologashvili, T; Tille, JC; Walpoth, BH; Yakub, A | 1 |
Kawamoto, S; Kumagai, K; Masaki, N; Saijo, Y; Saiki, Y; Sato, A; Suzuki, Y; Tabayashi, K; Takahashi, G; Watanabe, M | 1 |
3 other study(ies) available for caprolactone and Graft Occlusion, Vascular
Article | Year |
---|---|
Poly (
Topics: Animals; Caproates; Dioxanes; Graft Occlusion, Vascular; Hyperplasia; Lactones; Prednisone; Tunica Intima; Vascular Patency | 2022 |
Effect of implantation site on outcome of tissue-engineered vascular grafts.
Topics: Animals; Aorta, Abdominal; Blood Vessel Prosthesis; Blood Vessel Prosthesis Implantation; Caproates; Carotid Arteries; Graft Occlusion, Vascular; Lactones; Models, Animal; Polyesters; Rats; Rats, Sprague-Dawley; Vascular Patency | 2019 |
A novel biodegradable external mesh stent improved long-term patency of vein grafts by inhibiting intimal-medial hyperplasia in an experimental canine model.
Topics: Absorbable Implants; Animals; Blood Vessel Prosthesis Implantation; Caproates; Disease Models, Animal; Dogs; Femoral Artery; Femoral Vein; Graft Occlusion, Vascular; Hyperplasia; Lactones; Prosthesis Design; Stents; Surgical Mesh; Tunica Intima; Tunica Media; Vascular Patency | 2016 |